Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

S-236 cream may be used to promote barrier repair in atopic dermatitis

March 8, 2006

Studies assess antibacterial, antiinflammatory activity of AN-0128

March 7, 2006

R-115866 demonstrates efficacy and safety in phase IIa psoriasis trial

March 7, 2006

U.S. clinical data verify safety and efficacy of MAS-063DP for atopic dermatitis

March 7, 2006

Celgene presents preliminary phase II data on CC-10004 for severe psoriasis

March 7, 2006

R-850 shows good safety and efficacy profile in actinic keratosis

March 6, 2006

Endocannabinoid-derived topical treatment for atopic dermatitis

March 6, 2006

Epitan changes name to Clinuvel, initiates new program in actinic keratosis

March 2, 2006

Statistically significant results in Levulan PDT study

March 2, 2006

Oracea filed for approval in U.K.

Feb. 28, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...